Susan Lanza-Jacoby Selected Research

Lipoproteins (Lipoprotein)

1/2003

Hyperlipoproteinemic low-density lipoprotein receptor-deficient mice are more susceptible to sepsis than corresponding wild-type mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Susan Lanza-Jacoby Research Topics

Disease

7	Neoplasms (Cancer) 12/2018 - 12/2003
6	Breast Neoplasms (Breast Cancer) 12/2018 - 12/2003
2	Atherosclerosis 10/2010 - 05/2008
1	Pancreatic Neoplasms (Pancreatic Cancer) 09/2015
1	Abdominal Pain (Pain, Abdominal) 01/2014
1	Diarrhea 01/2014
1	Gastroenteritis 01/2014
1	Inflammation (Inflammations) 01/2014
1	Carcinogenesis 11/2009
1	Myocardial Infarction 05/2008
1	Melanoma (Melanoma, Malignant) 01/2007
1	Neoplasm Metastasis (Metastasis) 12/2003
1	Acute-Phase Reaction 01/2003
1	Infections 01/2003
1	Sepsis (Septicemia) 01/2003
1	Endotoxemia 01/2003

Drug/Important Bio-Agent (IBA)

5	Prostaglandin-Endoperoxide Synthases (Cyclooxygenase)IBA 01/2014 - 12/2003
4	Proteins (Proteins, Gene)FDA Link 10/2010 - 01/2003
4	Celecoxib (Celebrex)FDA Link 10/2010 - 12/2003
3	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 10/2010 - 12/2003
3	ProstaglandinsIBA 10/2010 - 12/2003
2	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2018 - 09/2015
2	Estrogen ReceptorsIBA 01/2014 - 05/2013
2	Vascular Cell Adhesion Molecule-1 (Vascular Cell Adhesion Molecule 1)IBA 10/2010 - 05/2008
2	Apolipoproteins E (ApoE)IBA 10/2010 - 05/2008
2	Cell Adhesion MoleculesIBA 10/2010 - 05/2008
1	Docetaxel (Taxotere)FDA Link 12/2018
1	3,3'-diindolylmethane (diindolylmethane)IBA 12/2018
1	Metformin (Glucophage)FDA LinkGeneric 09/2015
1	Glucose (Dextrose)FDA LinkGeneric 09/2015
1	Peroxisome ProliferatorsIBA 01/2014
1	NexrutineIBA 01/2014
1	Histone Deacetylase InhibitorsIBA 05/2013
1	Histone Deacetylases (Histone Deacetylase)IBA 05/2013
1	theasinensin AIBA 05/2013
1	CurcuminIBA 05/2013
1	trichostatin A (A 300)IBA 05/2013
1	Metalloproteases (Metalloproteinases)IBA 10/2010
1	Atorvastatin (Lipitor)FDA Link 10/2010
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 10/2010
1	Matrix Metalloproteinases (MMPs)IBA 10/2010
1	PPAR gammaIBA 11/2009
1	LigandsIBA 11/2009
1	Rosiglitazone (Avandia)FDA Link 11/2009
1	Troglitazone (Rezulin)FDA Link 11/2009
1	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 05/2008
1	Glutathione (Reduced Glutathione)IBA 01/2007
1	quinone (benzoquinone)IBA 01/2007
1	QuercetinIBA 01/2007
1	Monophenol Monooxygenase (Tyrosinase)IBA 01/2007
1	ErbB Receptors (EGF Receptor)IBA 10/2006
1	Cyclooxygenase 2 (Cyclooxygenase-2)IBA 10/2006
1	Gefitinib (Iressa)FDA Link 10/2006
1	4- (5- (4- chlorophenyl)- 3- (trifluoromethyl)- 1H- pyrazol- 1- yl)benzenesulfonamideIBA 04/2004
1	SC 560IBA 12/2003
1	Epoprostenol (Prostacyclin)FDA LinkGeneric 12/2003
1	Serum Amyloid A Protein (Serum Amyloid A)IBA 01/2003
1	oxidized low density lipoproteinIBA 01/2003
1	lipopolysaccharide-binding proteinIBA 01/2003
1	Lipoproteins (Lipoprotein)IBA 01/2003
1	InterleukinsIBA 01/2003
1	LDL Receptors (LDL Receptor)IBA 01/2003

Therapy/Procedure

2	Drug Therapy (Chemotherapy) 12/2018 - 01/2007
1	Therapeutics 05/2013
1	Radiotherapy 04/2004
1	Punctures 01/2003
1	Ligation 01/2003